Subscribe to Newsletter

Subspecialties

Subspecialties Neuro-ophthalmology

The Artificial Vision Endgame

Skip the retina and the optic nerve – and stimulate the brain directly.

Subspecialties Retina

The Clinical Advantages of SS OCT Angio™

| Sponsored by Topcon Healthcare

A summary of the Topcon-sponsored satellite symposium held at Euretina, Copenhagen, September 2016.

Subspecialties Glaucoma

Dual Blade, Single Purpose

Malik Kahook on the Kahook Dual Blade.

Subspecialties Cornea / Ocular Surface

Dry Eye Clinical Trials

| Ruth Steer

An analysis of dry eye clinical trials.

Subspecialties Professional Development

Adding Another String to Your Bow

| Inder Paul Singh

How and why I started offering laser vitreolysis at my practice.

Subspecialties Retina

PR – 10 Steps to Success

| Mark Hillen

Pneumatic retinopexy – an effective, inexpensive alternative to vitrectomy and scleral buckling?

Subspecialties Retina

The Importance of Good PR

| Paul Tornambe

Pneumatic retinopexy – an effective, inexpensive alternative to vitrectomy and scleral buckling?

Subspecialties Glaucoma

Dropping the Ball

| Ivan Goldberg

Non-adherence is a bigger threat to optimal outcomes than missed appointments in glaucoma management

Subspecialties Retina

The Right Design

| Philip Rosenfeld

Successful clinical trials - it’s all about the endpoints, says Philip Rosenfeld.

Subspecialties Glaucoma

High On a Low Supply?

| Mark Hillen

OCT angiography discriminates between POAG, NTG and normal patients.

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer element

This new disclaimer element is now part of all brands. It is editable on the start page and will be shown on all pages

Once confirmed we store a cookie to not show the disclaimer again.